Tema Oncology ETF (NASDAQ:CANC) Shares Up 1.7% – Time to Buy?

Tema Oncology ETF (NASDAQ:CANC) shares rose 1.7% during trading on Tuesday . The company traded as high as $35.53 and last traded at $35.53. Approximately 20,763 shares changed hands during mid-day trading, an increase of 46% from the average daily volume of 14,243 shares. The stock had previously closed at $34.92.

Tema Oncology ETF Stock Up 1.7%

The firm has a 50 day moving average price of $30.46 and a 200 day moving average price of $27.34. The stock has a market cap of $99.13 million, a P/E ratio of 20.39 and a beta of 1.00.

Institutional Investors Weigh In On Tema Oncology ETF

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CANC. Thrivent Financial for Lutherans lifted its holdings in Tema Oncology ETF by 658.7% during the second quarter. Thrivent Financial for Lutherans now owns 957,475 shares of the company’s stock valued at $23,673,000 after purchasing an additional 831,281 shares in the last quarter. Flow Traders U.S. LLC bought a new stake in shares of Tema Oncology ETF during the 3rd quarter valued at $630,000. Jane Street Group LLC purchased a new position in shares of Tema Oncology ETF during the 1st quarter valued at $213,000. Finally, Banque Transatlantique SA purchased a new position in shares of Tema Oncology ETF during the 1st quarter valued at $39,000.

About Tema Oncology ETF

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.